Cargando…
Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers
Significant advances in our knowledge of cancer genomes are rapidly changing the way we think about tumor biology and the heterogeneity of cancer. Recent successes in genomically-guided treatment approaches accompanied by more sophisticated sequencing techniques have paved the way for deeper investi...
Autores principales: | Paratala, Bhavna S., Dolfi, Sonia C., Khiabanian, Hossein, Rodriguez-Rodriguez, Lorna, Ganesan, Shridar, Hirshfield, Kim M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756769/ https://www.ncbi.nlm.nih.gov/pubmed/26917980 http://dx.doi.org/10.4137/BIC.S34417 |
Ejemplares similares
-
RET rearrangements are actionable alterations in breast cancer
por: Paratala, Bhavna S., et al.
Publicado: (2018) -
Riluzole exerts distinct antitumor effects from a metabotropic glutamate receptor 1-specific inhibitor on breast cancer cells
por: Dolfi, Sonia C, et al.
Publicado: (2017) -
Role of Biomarkers in the Development of PARP Inhibitors
por: Ganguly, Bratati, et al.
Publicado: (2016) -
Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment
por: Rojas, Veronica, et al.
Publicado: (2016) -
Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer
por: Gorshein, Elan, et al.
Publicado: (2021)